Literature DB >> 16151224

Inactivation of the 20S proteasome in Streptomyces lividans and its influence on the production of heterologous proteins.

Bin Hong1, Lifei Wang1, Elke Lammertyn2, Nick Geukens2, Lieve Van Mellaert2, Yuan Li1, Jozef Anné2.   

Abstract

Proteasomes are self-compartmentalizing proteases first discovered in eukaryotes but also occurring in archaea and in bacteria belonging to the order Actinomycetales. In bacteria, proteasomes have so far no known function. In order to evaluate the influence of the 20S proteasome on the production of heterologous proteins by Streptomyces lividans TK24, the production of a number of heterologous proteins, including soluble human tumour necrosis factor receptor II (shuTNFRII) and salmon calcitonin (sCT), was compared with the wild-type TK24, a proteasome-deficient mutant designated PRO41 and a strain complemented for the disrupted proteasome genes (strain PRO41R). S. lividans cells lacking intact proteasome genes are phenotypically indistinguishable from the wild-type or the complemented strain containing functional proteasomes. Using the expression and secretion signals of the subtilisin inhibitor of Streptomyces venezuelae CBS762.70 (Vsi) for shuTNFRII and those of tyrosinase of Streptomyces antibioticus (MelC1) for the production of sCT, both proteins were secreted in significantly higher amounts in the strain PRO41 than in the wild-type S. lividans TK24 or the complemented strain PRO41R. However, the secretion of other heterologous proteins such as shuTNFRI was not enhanced in the proteasome-deficient strain. This suggests that S. lividans TK24 can degrade some heterologous proteins in a proteasome-dependent fashion. The proteasome-deficient strain may therefore be useful for the efficient production of these heterologous proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151224     DOI: 10.1099/mic.0.28034-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  8 in total

1.  Bacterial self-resistance to the natural proteasome inhibitor salinosporamide A.

Authors:  Andrew J Kale; Ryan P McGlinchey; Anna Lechner; Bradley S Moore
Journal:  ACS Chem Biol       Date:  2011-09-26       Impact factor: 5.100

Review 2.  Bacterial Proteasomes.

Authors:  Jordan B Jastrab; K Heran Darwin
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

3.  Molecular analysis of the prokaryotic ubiquitin-like protein (Pup) conjugation pathway in Mycobacterium tuberculosis.

Authors:  Francisca A Cerda-Maira; Michael J Pearce; Michele Fuortes; William R Bishai; Stevan R Hubbard; K Heran Darwin
Journal:  Mol Microbiol       Date:  2010-09       Impact factor: 3.501

4.  The Absence of Pupylation (Prokaryotic Ubiquitin-Like Protein Modification) Affects Morphological and Physiological Differentiation in Streptomyces coelicolor.

Authors:  Hasna Boubakri; Nicolas Seghezzi; Magalie Duchateau; Myriam Gominet; Olga Kofroňová; Oldřich Benada; Philippe Mazodier; Jean-Luc Pernodet
Journal:  J Bacteriol       Date:  2015-08-17       Impact factor: 3.490

5.  The Mycobacterium tuberculosis proteasome active site threonine is essential for persistence yet dispensable for replication and resistance to nitric oxide.

Authors:  Sheetal Gandotra; Maria B Lebron; Sabine Ehrt
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

6.  In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice.

Authors:  Sheetal Gandotra; Dirk Schnappinger; Mercedes Monteleone; Wolfgang Hillen; Sabine Ehrt
Journal:  Nat Med       Date:  2007-12-02       Impact factor: 53.440

Review 7.  Pupylation versus ubiquitylation: tagging for proteasome-dependent degradation.

Authors:  Kristin E Burns; K Heran Darwin
Journal:  Cell Microbiol       Date:  2010-01-26       Impact factor: 3.715

Review 8.  The pupylation pathway and its role in mycobacteria.

Authors:  Jonas Barandun; Cyrille L Delley; Eilika Weber-Ban
Journal:  BMC Biol       Date:  2012-11-30       Impact factor: 7.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.